By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the 5th Gene Therapy for Neurological Disorders Summit, where groundbreaking advancements in gene therapy for central nervous system (CNS) disorders take center stage. Despite the challenges faced by gene therapy developers in 2022, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have affirmed the transformative potential of gene therapies within the CNS community.This comprehensive 4-day event is designed to keep you at the forefront of cutting-edge developments, enabling you to overcome delivery challenges, address translational bottlenecks, and forge a robust clinical development strategy. With a program tailored for professionals ranging from Discovery through to Clinical Development, this summit provides a unique platform for in-depth discussions, delivering essential insights and practical knowledge.By capitalizing on the renewed sense of direction in the field of neurological gene therapy, this event presents an unprecedented opportunity for the community to optimize the potential of gene therapies targeting neurological disorders. With over 200 gene therapy and neurology leaders in attendance, this summit fosters collaboration and networking among experts, driving the next wave of innovation in CNS gene therapies.Join us as we delve into the latest breakthroughs, explore strategies for successful clinical development, and accelerate the realization of transformative gene therapies for neurological disorders. Together, we will shape the future of gene therapy, revolutionizing treatment options and improving the lives of patients worldwide.
Grow with industry shapers and explore the forefront of gene therapy for neurological disorders.
Gain insights from leading experts through scientific presentations and expand knowledge of gene therapy advancements and preclinical and clinical studies.
Engage in stimulating discussions and establish meaningful connections. Explore cutting-edge technologies and novel approaches showcased by industry leaders.
Witness the transformative potential of gene therapy in neurologically changing patients’ lives and leave the conference with renewed motivation.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Make faster and better informed drug development decisions In partnership with the world’s leading drug development experts to help you keep up with the pace of preclinical and clinical research developments.
Our mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.